Qiagen N.V. (QGEN): Price and Financial Metrics

QGEN POWR Grades

• QGEN scores best on the Stability dimension, with a Stability rank ahead of 83.94% of US stocks.
• The strongest trend for QGEN is in Growth, which has been heading down over the past 52 weeks.
• QGEN ranks lowest in Momentum; there it ranks in the 50th percentile.

QGEN Stock Summary

• QGEN has a market capitalization of $12,239,424,080 -- more than approximately 82.81% of US stocks.
• Over the past twelve months, QGEN has reported earnings growth of 101.99%, putting it ahead of 80.55% of US stocks in our set.
• In terms of volatility of its share price, QGEN is more volatile than just 11.19% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to Qiagen Nv, a group of peers worth examining would be LFUS, BDC, FOXF, HPE, and ANGO.
• Visit QGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.qiagen.com.

QGEN Valuation Summary

• In comparison to the median Healthcare stock, QGEN's EV/EBIT ratio is 25.94% lower, now standing at 21.7.
• QGEN's price/earnings ratio has moved down 50.8 over the prior 239 months.
• Over the past 239 months, QGEN's price/sales ratio has gone down 4.3.

Below are key valuation metrics over time for QGEN.

QGEN Growth Metrics

• Its year over year net income to common stockholders growth rate is now at 1540.26%.
• The 5 year price growth rate now stands at 95.37%.
• Its 3 year price growth rate is now at 56.88%.

Over the past 30 months, QGEN's revenue has gone up $687,663,000.

The table below shows QGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	2,189.511	592.237	479.869
2021-03-31	2,065.455	570.52	448.582
2020-12-31	1,870.346	457.806	359.188
2020-12-31	1,870.346	457.806	359.188
2020-09-30	1,712.584	297.524	191.435
2020-09-30	1,712.584	297.524	191.435

QGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QGEN has a Quality Grade of B, ranking ahead of 78.67% of graded US stocks.
• QGEN's asset turnover comes in at 0.375 -- ranking 126th of 681 Pharmaceutical Products stocks.
• ALNY, RARE, and TXMD are the stocks whose asset turnover ratios are most correlated with QGEN.

The table below shows QGEN's key quality metrics over time.